Gene knockdown of γ-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme

被引:57
作者
Huynh, TT [1 ]
Huynh, VT [1 ]
Harmon, MA [1 ]
Phillips, MA [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA
关键词
D O I
10.1074/jbc.M306306200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The parasitic protozoa Trypanosoma brucei utilizes a novel cofactor (trypanothione, T(SH)(2)), which is a conjugate of GSH and spermidine, to maintain cellular redox balance. gamma-Glutamylcysteine synthetase (gamma-GCS) catalyzes the first step in the biosynthesis of GSH. To evaluate the importance of thiol metabolism to the parasite, RNA(i) methods were used to knock down gene expression of gamma-GCS in procyclic T. brucei cells. Induction of gamma-GCS RNA(i) with tetracycline led to cell death within 4-6 days post-induction. Cell death was preceded by the depletion of the gamma-GCS protein and RNA and by the loss of the cellular pools of GSH and T(SH)(2). The addition of GSH (80 muM) to cell cultures rescued the RNA(i) cell death phenotype and restored the intracellular thiol pools to wild-type levels. Treatment of cells with buthionine sulfoximine (BSO), an enzyme-activated inhibitor of gamma-GCS, also resulted in cell death. However, the toxicity of the inhibitor was not reversed by GSH, suggesting that BSO has more than one cellular target. BSO depletes intracellular thiols to a similar extent as gamma-GCS RNA(i); however, addition of GSH did not restore the pools of GSH and T( SH) 2. These data suggest that BSO also acts to inhibit the transport of GSH or its peptide metabolites into the cell. The ability of BSO to inhibit both synthesis and transport of GSH likely makes it a more effective cytotoxic agent than an inhibitor with a single mode of action. Finally the potential for the T(SH)(2) biosynthetic enzymes to be regulated in response to reduced thiol levels was studied. The expression levels of ornithine decarboxylase and of S-adenosylmethionine decarboxylase, two essential enzymes in spermidine biosynthesis, remained constant in induced gamma-GCS RNA(i) cell lines.
引用
收藏
页码:39794 / 39800
页数:7
相关论文
共 54 条
[1]   Substrate binding determinants of trypanosoma brucei γ-glutamylcysteine synthetase [J].
Abbott, JJ ;
Ford, JL ;
Phillips, MA .
BIOCHEMISTRY, 2002, 41 (08) :2741-2750
[2]   Structure prediction and active site analysis of the metal binding determinants γ-glutamyleysteine synthetase [J].
Abbott, JJ ;
Pei, JM ;
Ford, JL ;
Qi, Y ;
Grishin, VN ;
Phillips, MA ;
Grishin, NV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42099-42107
[3]   INHIBITION OF GLUTATHIONE SYNTHESIS AS A CHEMOTHERAPEUTIC STRATEGY FOR TRYPANOSOMIASIS [J].
ARRICK, BA ;
GRIFFITH, OW ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :720-725
[4]   Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents [J].
Augustyns, K ;
Amssoms, K ;
Yamani, A ;
Rajan, PK ;
Haemers, A .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (12) :1117-1141
[5]   BIOCHEMICAL-CHANGES ASSOCIATED WITH ALPHA-DIFLUOROMETHYLORNITHINE UPTAKE AND RESISTANCE IN TRYPANOSOMA-BRUCEI [J].
BELLOFATTO, V ;
FAIRLAMB, AH ;
HENDERSON, GB ;
CROSS, GAM .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1987, 25 (03) :227-238
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Trypanosoma brucei γ-glutamylcysteine synthetase -: Characterization of the kinetic mechanism and the role of Cys-319 in cystamine inactivation [J].
Brekken, DL ;
Phillips, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26317-26322
[8]  
BRUN R, 1979, ACTA TROP, V36, P289
[9]   Chemotherapy of human African trypanosomiasis [J].
Burchmore, RJS ;
Ogbunude, POJ ;
Enanga, B ;
Barrett, MP .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (04) :257-267
[10]   The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis [J].
Carter, KC ;
Sundar, S ;
Spickett, C ;
Pereira, OC ;
Mullen, AB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) :1529-1535